Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole for improvement of ADHD symptoms
IRCT20090117001556N151Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ropinirole in attention deficit hyperactivity disorder (ADHD), sponsored by Tehran University of Medical Sciences. Started Jul 2023; status: completed.
02
Drugs
ropinirole
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20090117001556N151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N151.